IP Library Granted Patent US 8,226,916
Granted Patent B2
US 8,226,916 · App. 13/298,970 · Granted Jul 24, 2012

Conversion of nitrogen dioxide (NO

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,226,916
App. No.
13/298,970
Granted
Jul 24, 2012
Kind
B2
Abstract

Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.

Claims (16)

1. A method for converting nitrogen dioxide to nitric oxide comprising:

delivering a gas flow including nitrogen dioxide into a receptacle through an inlet, wherein the receptacle includes the inlet, an outlet and an antioxidant; and

fluidly communicating the gas flow through the receptacle to the outlet, such that the gas flow contacts the antioxidant, which converts the nitrogen dioxide in the gas flow to nitric oxide.

2. The method of claim 1 , wherein the receptacle further comprises a surface-active material.

3. The method of claim 2 , wherein the antioxidant is included on the surface active material.

4. The method of claim 2 , wherein the surface-active material comprises a substrate that retains water.

5. The method of claim 2 , wherein the surface-active material comprises a silica gel.

6. The method of claim 1 , wherein the receptacle comprises a cartridge.

7. The method of claim 1 , wherein the antioxidant comprises ascorbic acid, alpha tocopherol or gamma tocopherol.

8. The method of claim 1 , further comprising diffusing nitrogen dioxide into the gas flow from a permeation cell having liquid nitrogen dioxide.

9. The method of claim 1 , wherein the receptacle is a first receptacle and the method further includes delivering a gas flow from the outlet of the first receptacle to an inlet in the second receptacle, wherein the second receptacle includes the inlet, an outlet, and an antioxidant.

10. The method of claim 9 , wherein the antioxidant in the first receptacle and the antioxidant in the second receptacle are the same.

11. The method of claim 9 , wherein the second receptacle further comprises a surface-active material.

12. The method of claim 1 , wherein the receptacle is a first receptacle and the method further includes delivering a gas flow from the outlet of the first receptacle to an inlet in the second receptacle, wherein the second receptacle includes the inlet, an outlet, and activated alumina.

13. The method of claim 1 , further comprising supplying oxygen into the gas flow prior to delivering the gas flow including nitrogen dioxide into the receptacle through the inlet.

14. The method of claim 1 , further comprising delivering the nitric oxide to a mammal.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2021
From: ROUNBEHLER, DAVID P.; FINE, DAVID H.
To: CYTERRA CORPORATION
Reel/Frame 057360/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2021
From: CYTERRA CORPORATION
To: GENO LLC
Reel/Frame 057360/0096 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Jun 6, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 046304/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2012
From: ROUNBEHLER, DAVID P.; FINE, DAVID H.
To: GENO LLC
Reel/Frame 028441/0469 →